Nephrocare acquires Philippines dialysis assets for PHP 72.2 million

1 min read     Updated on 27 May 2026, 07:08 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Nephrocare Health Services Limited expanded its renal care presence by acquiring dialysis center assets in the Philippines through its subsidiary. The company signed two Asset Transfer Agreements worth a total of PHP 72.2 million, approximately INR 11.24 Crores, with Northern Mindanao Dialysis Clinic Inc. and Aliaga Hemodialysis Centre Inc. The transactions, executed on May 26, 2026, are arm's length deals and do not involve related parties.

powered bylight_fuzz_icon
41361891

*this image is generated using AI for illustrative purposes only.

nephrocare health services has expanded its international footprint through its overseas step-down wholly-owned subsidiary, Nephrocare Health Care Services Philippines Inc. The subsidiary entered into two separate Asset Transfer Agreements (ATAs) to acquire identified assets pertaining to dialysis centers in the Philippines. The total consideration for these acquisitions amounts to PHP 72,200,000.00, approximately INR 11.24 Crores, strengthening the company's presence in the renal care market.

The first agreement was executed on May 26, 2026, with Northern Mindanao Dialysis Clinic Inc. (NMDCl). This ATA, dated May 22, 2026, covers the acquisition of assets for a dialysis center located at Cagayan De Oro City, Misamis Oriental. The transaction value for this center is PHP 27,400,000.00, which is approximately INR 4.25 Crores.

The second agreement was also executed on May 26, 2026, with Aliaga Hemodialysis Centre Inc. (Aliaga). This acquisition involves assets for a dialysis center situated at Brgy. Sto. Rosario, Aliaga, Nueva Ecija. The consideration for this center is PHP 44,800,000.00, approximately INR 6.99 Crores.

The disclosures confirm that the sellers in both transactions are not related to the promoter or promoter group of Nephrocare Health Services Limited. Consequently, these transactions do not fall under related party transactions and were conducted at arm's length. The agreements do not confer any special rights, such as the right to appoint directors or restrict changes in capital structure.

Details of Acquisition Agreements

Sr. No Particulars Northern Mindanao Dialysis Clinic Inc. Aliaga Hemodialysis Centre Inc.
1 Location Cagayan De Oro City, Misamis Oriental Brgy. Sto. Rosario, Aliaga, Nueva Ecija
2 Agreement Date May 22, 2026 May 26, 2026
3 Execution Date May 26, 2026 May 26, 2026
4 Total Consideration (PHP) PHP 27,400,000.00 PHP 44,800,000.00
5 Approximate Value (INR) INR 4.25 Crores INR 6.99 Crores

The information was submitted to the exchanges in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kishore Kathri, Company Secretary & Compliance Officer, signed the disclosure on May 26, 2026.

Historical Stock Returns for Nephrocare Health Services

1 Day5 Days1 Month6 Months1 Year5 Years
-1.85%+0.03%+12.33%+53.50%+53.50%+53.50%

What is the expected timeline for integrating these newly acquired dialysis centers into Nephrocare's operational network?

How will this acquisition impact Nephrocare's revenue and profitability in the upcoming fiscal year?

Does Nephrocare plan to pursue further acquisitions in the Philippines or other international markets to expand its footprint?

Nephrocare Health Services
View Company Insights
View All News
like16
dislike

Nephrocare Health Services investor meet on June 15-16

0 min read     Updated on 27 May 2026, 07:00 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Nephrocare Health Services Limited will conduct a non-deal roadshow for analysts and institutional investors on June 15 and 16, 2026, in Mumbai. Hosted by Citi, the event will feature group and one-on-one interactions starting at 10:00 A.M. IST. The company confirmed that no unpublished price sensitive information will be shared during the meeting.

powered bylight_fuzz_icon
41362208

*this image is generated using AI for illustrative purposes only.

Nephrocare Health Services Limited has scheduled a non-deal roadshow for analysts and institutional investors on June 15 and 16, 2026, in Mumbai. The event, hosted by Citi, will facilitate group and one-on-one interactions starting at 10:00 A.M. IST onwards. The company clarified that discussions will be strictly based on publicly available information, with no intention to disclose any unpublished price sensitive information (UPSI).

The disclosure was made pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kishore Kathri, Company Secretary & Compliance Officer, signed the intimation on May 26, 2026. The company noted that the schedule remains subject to changes due to exigencies on the part of the host or the company.

Event Details

Date & Time Event Host Nature of Meeting Place
15th & 16th June, 2026
10:00 A.M. (IST) Onwards
Non-Deal Roadshow Citi Group / 1*1 Meeting Mumbai

Historical Stock Returns for Nephrocare Health Services

1 Day5 Days1 Month6 Months1 Year5 Years
-1.85%+0.03%+12.33%+53.50%+53.50%+53.50%

What key performance indicators or strategic updates is Nephrocare likely to emphasize during the roadshow to attract institutional interest?

How might the market react to the roadshow in terms of stock volatility, given the strict adherence to publicly available information?

Could this roadsignal potential upcoming corporate actions, such as a fundraising round or M&A activity, despite being labeled as non-deal?

Nephrocare Health Services
View Company Insights
View All News
like15
dislike

More News on Nephrocare Health Services

1 Year Returns:+53.50%